+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Use of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction



Use of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction



Official Gazette of the United States Patent and Trademark Office Patents 1247(2)



A method for the prevention or treatment of cerebellar dysfunction, particularly cerebellar ataxia, by the use of riluzole or a pharmaceutically acceptable salt thereof.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 036012627

Download citation: RISBibTeXText


Related references

2 amino 6 trifluoromethoxybenzothiazole a possible antagonist of excitatory amino acid neurotransmission 1. anticonvulsant properties. Neuropharmacology 24(8): 767-774, 1985

2 amino 6 trifluoromethoxybenzothiazole pk 26124 a proposed antagonist of excitatory amino acid neurotransmission does not produce phencyclidine like behavioral effects in pigeons rats and rhesus monkeys. Neuropharmacology 27(7): 771-775, 1988

Pk 26124 2 amino 6 trifluoromethoxybenzothiazole a possible glutamate antagonist. Society for Neuroscience Abstracts 10(1): 230, 1984

Effects of riluzole 2 amino 6 trifluoromethoxybenzothiazole on striatal neurochemical markers in the rat with special reference to the dopamine choline gaba and glutamate synaptosomal high affinity uptake systems. Fundamental and Clinical Pharmacology 6(4-5): 177-184, 1992

Cerebellar excitatory amino acid dysfunction in alzheimers disease. Neuropathology and Applied Neurobiology 16(3): 260-261, 1990

Phosphonate analogs of acidic amino acids inhibition of excitatory amino acid transmitter binding to cerebellar membranes and of the stimulation of cerebellar cyclic gmp levels. Brain Research 238(2): 475-479, 1982

Postnantal cerebellar hypoplasia and dysfunction following methylazoxymethanol acetate treatment (38495). Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 148(1): 156-159, 1975

Pattern of otolith dysfunction in posterior inferior cerebellar artery territory cerebellar infarction. Journal of the Neurological Sciences 280(1-2): 65-70, 2009

Hypoglycemia-induced bilateral cerebellar dysfunction Cerebellar glucose kinetics on quantitative dynamic PET study. Neurology 52(6 Suppl. 2): A280, 1999

Cerebellar-motor dysfunction in schizophrenia and psychosis-risk: the importance of regional cerebellar analysis approaches. Frontiers in Psychiatry 5: 160, 2014

MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction. Multiple Sclerosis 15(7): 811-817, 2009

Cerebellar dysfunction in neuroleptic naive schizophrenia patients: clinical, cognitive, and neuroanatomic correlates of cerebellar neurologic signs. Biological Psychiatry 55(12): 1146-1153, 2004

Insulin-like growth factor-I improves cerebellar dysfunction but does not prevent cerebellar neurodegeneration in the calcium channel mutant mouse, leaner. Neurobiology of Disease 14(2): 157-165, 2003

Mobility impairment is associated with reduced microstructural integrity of the inferior and superior cerebellar peduncles in elderly with no clinical signs of cerebellar dysfunction. Neuroimage. Clinical 2: 332-340, 2013